U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In — ProPublica
Last November, the Department of Health and Human Services announced the elimination of “black box” warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a…